122 related articles for article (PubMed ID: 2461509)
1. The relationship of serotonin to depression in Parkinson's disease.
Mayeux R; Stern Y; Sano M; Williams JB; Cote LJ
Mov Disord; 1988; 3(3):237-44. PubMed ID: 2461509
[TBL] [Abstract][Full Text] [Related]
2. Depression in the patient with Parkinson's disease.
Mayeux R
J Clin Psychiatry; 1990 Jul; 51 Suppl():20-3; discussion 24-5. PubMed ID: 2195009
[TBL] [Abstract][Full Text] [Related]
3. [Study on the concentration of 5-hydroxyindoleacetic acid (5-HIAA) in the lumbar cerebrospinal fluid (CSF) in neurological diseases].
Fukuda H; Nakamura S; Hara K; Udaka F; Kameyama M
Rinsho Shinkeigaku; 1989 Sep; 29(9):1192-4. PubMed ID: 2480863
[TBL] [Abstract][Full Text] [Related]
4. The indoleamine hypothesis of depression: an overview and pilot study.
Zarcone VP; Berger PA; Brodie KH; Sack R; Barchas JD
Dis Nerv Syst; 1977 Aug; 38(8):646-53. PubMed ID: 328245
[TBL] [Abstract][Full Text] [Related]
5. Depression and serotonin metabolism: rationale for neurotransmitter precursor treatment.
Byerley WF; Risch SC
J Clin Psychopharmacol; 1985 Aug; 5(4):191-206. PubMed ID: 2410463
[TBL] [Abstract][Full Text] [Related]
6. Uncoupling of serotonergic and noradrenergic systems in depression: preliminary evidence from continuous cerebrospinal fluid sampling.
Geracioti TD; Loosen PT; Ekhator NN; Schmidt D; Chambliss B; Baker DG; Kasckow JW; Richtand NM; Keck PE; Ebert MH
Depress Anxiety; 1997; 6(3):89-94. PubMed ID: 9442982
[TBL] [Abstract][Full Text] [Related]
7. Depression and Parkinson's disease: possible role of serotonergic mechanisms.
Kostić VS; Djuricić BM; Covicković-Sternić N; Bumbasirević L; Nikolić M; Mrsulja BB
J Neurol; 1987 Feb; 234(2):94-6. PubMed ID: 2435855
[TBL] [Abstract][Full Text] [Related]
8. Mortality in Parkinson's disease and its association with dementia and depression.
Hughes TA; Ross HF; Mindham RH; Spokes EG
Acta Neurol Scand; 2004 Aug; 110(2):118-23. PubMed ID: 15242420
[TBL] [Abstract][Full Text] [Related]
9. Measurement of 5-hydroxyindole compounds during L-5-HTP treatment in depressed patients.
Takahashi S; Takahashi R; Masumura I; Miike A
Folia Psychiatr Neurol Jpn; 1976; 30(4):461-73. PubMed ID: 1087913
[TBL] [Abstract][Full Text] [Related]
10. Dementia in Thai patients with Parkinson's disease: analysis of 132 patients.
Poungvarin N; Prayoonwiwat N; Devahastin V; Viriyavejakul A
J Med Assoc Thai; 1996 May; 79(5):278-84. PubMed ID: 8708518
[TBL] [Abstract][Full Text] [Related]
11. Behavioral manifestations of movement disorders. Parkinson's and Huntington's disease.
Mayeux R
Neurol Clin; 1984 Aug; 2(3):527-40. PubMed ID: 6085395
[TBL] [Abstract][Full Text] [Related]
12. Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease.
Kish SJ; Tong J; Hornykiewicz O; Rajput A; Chang LJ; Guttman M; Furukawa Y
Brain; 2008 Jan; 131(Pt 1):120-31. PubMed ID: 17956909
[TBL] [Abstract][Full Text] [Related]
13. [The relevance of dopamine agonists in the treatment of depression].
Clausius N; Born C; Grunze H
Neuropsychiatr; 2009; 23(1):15-25. PubMed ID: 19272288
[TBL] [Abstract][Full Text] [Related]
14. Subthreshold depression in patients with Parkinson's disease and dementia--clinical and demographic correlates.
Ehrt U; Brønnick K; De Deyn PP; Emre M; Tekin S; Lane R; Aarsland D
Int J Geriatr Psychiatry; 2007 Oct; 22(10):980-5. PubMed ID: 17393542
[TBL] [Abstract][Full Text] [Related]
15. 5-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment.
Stuerenburg HJ; Ganzer S; Müller-Thomsen T
Neuro Endocrinol Lett; 2004 Dec; 25(6):435-7. PubMed ID: 15665806
[TBL] [Abstract][Full Text] [Related]
16. A comparative study on neurochemistry of cerebrospinal fluid in advanced Parkinson's disease.
Liu H; Iacono RP; Schoonenberg T; Kuniyoshi S; Buchholz J
Neurobiol Dis; 1999 Feb; 6(1):35-42. PubMed ID: 10078971
[TBL] [Abstract][Full Text] [Related]
17. Coexisting dementia and depression in Parkinson's disease.
Sano M; Stern Y; Williams J; Coté L; Rosenstein R; Mayeux R
Arch Neurol; 1989 Dec; 46(12):1284-6. PubMed ID: 2480103
[TBL] [Abstract][Full Text] [Related]
18. [Prevalence of mental disorders in persons with Parkinson's disease].
de Rijk C; Bijl RV
Ned Tijdschr Geneeskd; 1998 Jan; 142(1):27-31. PubMed ID: 9556986
[TBL] [Abstract][Full Text] [Related]
19. Study of tryptophan metabolism via serotonin in cerebrospinal fluid of patients with noncommunicating hydrocephalus using a new endoscopic technique.
Comai S; Longatti P; Perin A; Bertazzo A; Ragazzi E; Costa CV; Allegri G
J Neurosci Res; 2006 Aug; 84(3):683-91. PubMed ID: 16721766
[TBL] [Abstract][Full Text] [Related]
20. CSF serotonin, 5-hydroxyindolacetic acid and neuropeptide Y levels in severe major depressive disorder.
Hou C; Jia F; Liu Y; Li L
Brain Res; 2006 Jun; 1095(1):154-8. PubMed ID: 16713589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
